Company Filing History:
1 out of 51 
1 out of 50 
1 out of 50 
Years Active: 2019
Title: Khadega A Abuelgasim: Innovator in Leukemia Treatment
Introduction
Khadega A Abuelgasim is a prominent inventor based in Riyadh, Saudi Arabia. She has made significant contributions to the field of medical science, particularly in the treatment of leukemia. Her innovative approach focuses on gene expression and its implications for patient care.
Latest Patents
Khadega holds a patent for a method of treating leukemia based on gene expression of clock genes. This method involves obtaining plasma samples from a patient at two different time points. It includes measuring the gene expression levels of core clock genes and peripheral clock genes. The effectiveness of a treatment is determined by analyzing the correlation of these gene expression levels, allowing for tailored patient care.
Career Highlights
Throughout her career, Khadega has worked with notable institutions such as National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences. Her work has been instrumental in advancing medical research and treatment methodologies.
Collaborations
Khadega has collaborated with esteemed colleagues, including Mohamed Boudjelal and Ahmed Al Askar. These partnerships have enhanced her research and contributed to her innovative projects.
Conclusion
Khadega A Abuelgasim is a trailblazer in the field of leukemia treatment, utilizing her expertise in gene expression to improve patient outcomes. Her contributions to medical science are invaluable and continue to inspire future innovations.